Top

Published in:

01-10-2010 | Journal club critique

Comparing different thrombolytic dosing regimens for treatment of acute pulmonary embolism

Authors: Ammar Ghanem, Sachin Yende

Published in: Critical Care | Issue 5/2010

Excerpt

Ch en Wang, Zh enguo Zhai, Yuanhua Yang, Qi Wu, Zhaozhong Cheng, Lirong Liang, Huaping Dai, Kewu Huang, Weixuan Lu, Zhonghe Zhang, Xiansheng Cheng, Ying H Shen, For the China Venous Thromboembolism (VTE) Study Group: Chest 2010, 137:254-262. Trial registration: clinicaltrials.gov; Identifier: NCT00781378. …

Capstick T, Henry MT: Efficacy of thrombolytic agents in the treatment of pulmonary embolism. Eur Respir J. 2005, 26: 864-874. 10.1183/09031936.05.00002505.CrossRefPubMed

Agnelli G, Becattini C, Kirschstein T: Thrombolysis vs heparin in the treatment of pulmonary embolism: a clinical outcome-based meta-analysis. Arch Intern Med. 2002, 162: 2537-2541. 10.1001/archinte.162.22.2537.CrossRefPubMed

Wan S, Quinlan DJ, Agnelli G, Eikelboom JW: Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials. Circulation. 2004, 110: 744-749. 10.1161/01.CIR.0000137826.09715.9C.CrossRefPubMed

Fiumara K, Kucher N, Fanikos J, Goldhaber SZ: Predictors of major hemorrhage following fibrinolysis for acute pulmonary embolism. Am J Cardiol. 2006, 97: 127-129. 10.1016/j.amjcard.2005.07.117.CrossRefPubMed

Goldhaber SZ, Agnelli G, Levine MN: Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis. An international multicenter randomized trial. The Bolus Alteplase Pulmonary Embolism Group. Chest. 1994, 106: 718-724. 10.1378/chest.106.3.718.CrossRefPubMed

Levine M, Hirsh J, Weitz J, Cruickshank M, Neemeh J, Turpie AG, Gent M: A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism. Chest. 1990, 98: 1473-1479. 10.1378/chest.98.6.1473.CrossRefPubMed

Wang C, Zhai Z, Yang Y, Wu Q, Cheng Z, Liang L, Dai H, Huang K, Lu W, Zhang Z, Cheng X, Shen YH: Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trial. Chest. 2010, 137: 254-262. 10.1378/chest.09-0765.CrossRefPubMed

Title: Comparing different thrombolytic dosing regimens for treatment of acute pulmonary embolism
Authors: Ammar Ghanem
Sachin Yende
Publication date: 01-10-2010
Publisher: BioMed Central
Published in: Critical Care / Issue 5/2010
Electronic ISSN: 1364-8535
DOI: https://doi.org/10.1186/cc9287

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Comparing different thrombolytic dosing regimens for treatment of acute pulmonary embolism

Excerpt

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 5/2010

Central venous O2 saturation and venous-to-arterial CO2 difference as complementary tools for goal-directed therapy during high-risk surgery

Too cold may not be so cool: spontaneous hypothermia as a marker of poor outcome after cardiac arrest

Variations in the length of stay of intensive care unit nonsurvivors in three scandinavian countries

Intensive care diaries reduce new onset post traumatic stress disorder following critical illness: a randomised, controlled trial

Clinical review: mechanical circulatory support for cardiogenic shock complicating acute myocardial infarction

Direct antimicrobial activity of antithrombin?